Pap test update.
Aust Fam Physician
; 36(3): 112-5, 2007 Mar.
Article
em En
| MEDLINE
| ID: mdl-17339970
ABSTRACT
BACKGROUND:
2006 was an eventful year in the area of screening to prevent cervical cancer. New screening guidelines were introduced nationally in July, and in November the Australian Government agreed to fund one of the human papillomavirus (HPV) vaccines, Gardasil, under the National Immunisation Program.OBJECTIVE:
This article discusses the cervical screening program and the Pap test in the era of HPV vaccination.DISCUSSION:
With the introduction of a vaccine to prevent the acquisition of significant genital HPV types, many practitioners will be questioning the continuing need for the Pap test. But for those women who have missed out on the vaccine, the Pap test will still play a crucial role in preventing the development of cervical cancer, and the vaccinated cohort will need to continue screening in some form as the vaccine does not cover all the HPV types responsible for anogenital cancer.
Buscar no Google
Bases de dados:
MEDLINE
Assunto principal:
Esfregaço Vaginal
/
Displasia do Colo do Útero
/
Neoplasias do Colo do Útero
/
Infecções por Papillomavirus
/
Vacinas contra Papillomavirus
Tipo de estudo:
Guideline
/
Prognostic_studies
/
Qualitative_research
/
Screening_studies
Limite:
Female
/
Humans
País/Região como assunto:
Oceania
Idioma:
En
Revista:
Aust Fam Physician
Ano de publicação:
2007
Tipo de documento:
Article
País de afiliação:
Austrália